Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/105009
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: The immunomodulatory small molecule imiquimod induces apoptosis in devil facial tumour cell lines
Author: Patchett, A.
Darby, J.
Tovar, C.
Lyons, A.
Woods, G.
Citation: PLoS ONE, 2016; 11(12)
Publisher: Public Library Science
Issue Date: 2016
ISSN: 1932-6203
1932-6203
Statement of
Responsibility: 
Amanda L. Patchett, Jocelyn M. Darby, Cesar Tovar, A. Bruce Lyons, Gregory M. Woods
Abstract: The survival of the Tasmanian devil (Sarcophilus harrisii) is threatened by devil facial tumour disease (DFTD). This transmissible cancer is usually fatal, and no successful treatments have been developed. In human studies, the small immunomodulatory molecule imiquimod is a successful immunotherapy, activating anti-tumour immunity via stimulation of toll-like receptor-7 (TLR7) signaling pathways. In addition, imiquimod is a potent inducer of apoptosis in human tumour cell lines via TLR7 independent mechanisms. Here we investigate the potential of imiquimod as a DFTD therapy through analysis of treated DFTD cell lines and Tasmanian devil fibroblasts. WST-8 proliferation assays and annexin V apoptosis assays were performed to monitor apoptosis, and changes to the expression of pro- and anti-apoptotic genes were analysed using qRT-PCR. Our results show that DFTD cell lines, but not Tasmanian devil fibroblasts, are sensitive to imiquimod-induced apoptosis in a time and concentration dependent manner. Induction of apoptosis was accompanied by down-regulation of the anti-apoptotic BCL2 and BCLXL genes, and up-regulation of the pro-apoptotic BIM gene. Continuous imiquimod treatment was required for these effects to occur. These results demonstrate that imiquimod can deregulate DFTD cell growth and survival in direct and targeted manner. In vivo, this may increase DFTD vulnerability to imiquimod-induced TLR7-mediated immune responses. Our findings have improved the current knowledge of imiquimod action in tumour cells for application to both DFTD and human cancer therapy.
Keywords: Cell Line, Tumor; Animals; Marsupialia; Humans; Facial Neoplasms; Skin Neoplasms; Aminoquinolines; Adjuvants, Immunologic; Apoptosis; Imiquimod
Rights: Copyright: © 2016 Patchett et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
RMID: 0030062802
DOI: 10.1371/journal.pone.0168068
Grant ID: http://purl.org/au-research/grants/arc/LP130100218
Appears in Collections:Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_105009.pdfPublished Version2.01 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.